Patents Assigned to Jyant Technologies, Inc.
  • Nanoformulations for plants
    Patent number: 10058093
    Abstract: The present application relates to a nanoparticle compositions and methods for targeted delivery of a bioactive agent to a plant. In one embodiment, the nanoparticle composition includes a coronatine-coated nanoparticle formulated to deliver one or more bioactive agent through plant stomata. A variety of bioactive agents may be included in the nanoparticles, including one or more bactericides, fungicides, insecticides, acaricides, miticides, nemanticides, molluscicides, herbicides, plant nutrients, fertilizers, plant growth regulators, or combinations thereof.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: August 28, 2018
    Assignee: JYANT TECHNOLOGIES, INC.
    Inventors: James W. Lillard, Jr., Rajesh Singh
  • Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
    Patent number: 9783588
    Abstract: This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: October 10, 2017
    Assignee: JYANT TECHNOLOGIES, INC.
    Inventor: James W. Lillard, Jr.
  • Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
    Patent number: 9493531
    Abstract: This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: November 15, 2016
    Assignee: JYANT TECHNOLOGIES, INC.
    Inventor: James W. Lillard, Jr.
  • Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
    Patent number: 9249204
    Abstract: This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: February 2, 2016
    Assignee: JYANT TECHNOLOGIES, INC.
    Inventor: James W. Lillard, Jr.
  • Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
    Patent number: 8987210
    Abstract: This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: March 24, 2015
    Assignee: Jyant Technologies, Inc.
    Inventor: James W. Lillard, Jr.
  • Nanoparticles for delivery of active agents
    Patent number: 8962030
    Abstract: Milled nanoparticles comprising a biologically active agent, at least one biopolymer and a coating containing at least one coating which is a polymer or ligand are produced using milling and coating techniques which have not previously been used for these applications.
    Type: Grant
    Filed: November 10, 2010
    Date of Patent: February 24, 2015
    Assignee: Jyant Technologies, Inc.
    Inventors: James W. Lillard, Rajesh Singh, Shailesh Singh